FOLFOX6 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

670 results for “FOLFOX6”

Trials

View all 658 →

Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases

44 participants · First posted Jan 11, 2012

Study on FOLFOX6 as First-line Therapy to Treat Recurrent or Metastatic Esophageal Cancer

60 participants · First posted May 24, 2012

Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)

15 participants · First posted Aug 22, 2011

News

View all 12 →

Nivolumab Plus Ipilimumab Demonstrates Superiority Over Chemotherapy in MSI-H/dMMR Metastatic Colorectal Cancer

High-Dose Vitamin D3 Fails to Improve Outcomes in Metastatic Colorectal Cancer, Phase 3 Trial Finds

ONO-4578 EP4 Antagonist Combination Shows Significant PFS Improvement in Advanced Gastric Cancer

Page 1 of 67